| RS1555533548 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533549 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533550 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533552 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533555 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533559 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis |
| RS1555533561 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533562 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555533566 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533569 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533571 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533587 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533589 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533609 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533621 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1555533628 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533631 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533636 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533638 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533641 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533644 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533648 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533650 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555533693 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555533754 |
ALDH3A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS1555533840 |
CTC1
|
Health Risk |
Likely pathogenic |
— |
| RS1555533842 |
NF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neurofibromatosis |
| RS1555533843 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533853 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533856 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533863 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555533871 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533873 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1555533875 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533880 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555533882 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555533883 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533887 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555533889 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534060 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555534067 |
CTCF
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555534093 |
CTCF
|
Health Risk |
Pathogenic |
— |
| RS1555534147 |
CTCF
|
Health Risk |
Pathogenic |
Inborn genetic diseases, CTCF-related neurodevelopmental disorder |
| RS1555534189 |
CTCF
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, CTCF-related neurodevelopmental disorder |
| RS1555534307 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534375 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555534378 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534379 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534380 |
NF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555534391 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534393 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534394 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534411 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534430 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555534432 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534433 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, familial spinal |
| RS1555534434 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555534435 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534472 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555534521 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555534595 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534596 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1555534600 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534609 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555534611 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534612 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Premature birth, Floppy infant |
| RS1555534616 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534618 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555534621 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534661 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534667 |
NF1
|
Health Risk |
Pathogenic |
Pilocytic astrocytoma, Neurofibromatosis |
| RS1555534669 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534673 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1555534677 |
NF1
|
Health Risk |
Pathogenic |
Cafe au lait spots, multiple |
| RS1555534680 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534697 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534708 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534712 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534726 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534735 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555534751 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534755 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555534766 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534770 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534775 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534859 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534885 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534886 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534893 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534907 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534913 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534917 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534918 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534919 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555534928 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534929 |
NF1
|
Health Risk |
Pathogenic |
Axillary freckling, Inguinal freckling |
| RS1555534930 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555534948 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555534950 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555534952 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |